ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Woodz13
|
501 |
172K |
6 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
501
|
172K
|
6
|
|
ASX - By Stock
|
AQC |
Re:
Ann: Application for quotation of securities - AQC
|
|
Woodz13
|
5 |
2.0K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
AQC |
Re:
Ann: Application for quotation of securities - AQC
|
|
Woodz13
|
5 |
2.0K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
AQC |
Re:
Ann: Application for quotation of securities - AQC
|
|
Woodz13
|
5 |
2.0K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
13K
|
4.8M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
13K
|
4.8M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
13K
|
4.8M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
13K
|
4.8M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Woodz13
|
72 |
24K |
4 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
72
|
24K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
1 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
9.1K
|
3.4M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
6 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
9.1K
|
3.4M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
1 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
9.1K
|
3.4M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Woodz13
|
22 |
11K |
4 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
22
|
11K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Woodz13
|
1K |
292K |
2 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
292K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
2 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
9.1K
|
3.4M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
1 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
9.1K
|
3.4M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
2 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
9.1K
|
3.4M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
1 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
9.1K
|
3.4M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Clears Development Path for BTX 1801
|
|
Woodz13
|
76 |
33K |
4 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
76
|
33K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
33c share price target by July 2021
|
|
Woodz13
|
273 |
128K |
3 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
273
|
128K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
2 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
9.1K
|
3.4M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Woodz13
|
9.1K |
3.4M |
1 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
9.1K
|
3.4M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
0 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
13K
|
4.8M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
10 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
13K
|
4.8M
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
0 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
13K
|
4.8M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Woodz13
|
13K |
4.8M |
0 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
13K
|
4.8M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
Woodz13
|
62 |
24K |
1 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
62
|
24K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
News articles and websites mentioning BOT
|
|
Woodz13
|
43 |
28K |
0 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
43
|
28K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
33c share price target by July 2021
|
|
Woodz13
|
273 |
128K |
5 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
273
|
128K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Objective Views on Lead product: BTX 1503 (Acne)
|
|
Woodz13
|
47 |
12K |
0 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
47
|
12K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Objective Views on Lead product: BTX 1503 (Acne)
|
|
Woodz13
|
47 |
12K |
0 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
47
|
12K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Objective Views on Lead product: BTX 1503 (Acne)
|
|
Woodz13
|
47 |
12K |
12 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
47
|
12K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BTX 1204 Atopic Dermatitis Phase 1b results
|
|
Woodz13
|
12 |
11K |
2 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
12
|
11K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BTX 1204 Atopic Dermatitis Phase 1b results
|
|
Woodz13
|
12 |
11K |
6 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
12
|
11K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BTX 1204 Atopic Dermatitis Phase 1b results
|
|
Woodz13
|
12 |
11K |
6 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
12
|
11K
|
6
|
|
ASX - By Stock
|
BOT |
BTX 1204 Atopic Dermatitis Phase 1b results
|
|
Woodz13
|
12 |
11K |
7 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
12
|
11K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Updated Investor Presentation with New BTX 1801 Data
|
|
Woodz13
|
6 |
5.4K |
7 |
20/06/19 |
20/06/19 |
ASX - By Stock
|
6
|
5.4K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
44c
|
|
Woodz13
|
184 |
88K |
1 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
184
|
88K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Completion of the Tranche 1 Placement
|
|
Woodz13
|
69 |
35K |
0 |
23/04/17 |
23/04/17 |
ASX - By Stock
|
69
|
35K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Completion of the Tranche 1 Placement
|
|
Woodz13
|
69 |
35K |
0 |
23/04/17 |
23/04/17 |
ASX - By Stock
|
69
|
35K
|
0
|
|